Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy

By sjmartinez • January 13, 2025

Goldman MP, Patel DM, Chang KZ, Davis RP, Edwards MS, Hurie JB, Sutsrim A, Velazquez-Ramirez G, Williams TK, Grandas OH, Freeman MB, McNally MM, Stevens SL, Bennett KM, Woo K, Carsten CG, Androes MP, Blas JV, Jones B, Patton RM, Parr R, Gandhi SS, York JW, Young CJ, Rabbani MU, Gardezi AI, Abdelnour LM, Lee T, Abusalah WM, Zayas CF, Hicks CW, Geetha D, Brown WM, Chen H, Allon M, Murea M; AV Access Consortium. Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy. JVS Vasc Insights. 2024;2:100108. doi: 10.1016/j.jvsvi.2024.100108. Epub 2024 Jun 7. PMID: 39802461; PMCID: PMC11720168.

Tags: Arteriovenous fistula, Arteriovenous graft, Hemodialysis vascular access, Nephrology, Publications, Randomized Controlled Trial

Advances in Organoid Research and Developmental Engineering

Hauser PV. Advances in Organoid Research and Developmental Engineering. Bioengineering (Basel). 2024 Dec 15;11(12):1275. doi: 10.3390/bioengineering11121275. PMID: 39768093.

Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantation

Chandran S, Vincenti F. Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantation. Am J Transplant. 2025 Jan;25(1):19-26.[...]

Hypertension Management in Women With a Multidisciplinary Approach

Nobakht N, Afshar Y, Vaseghi M, Li Z, Donangelo I, Lavretsky H, Mok T, Han CS, Nicholas SB. Hypertension Management in Women With a Multidisciplinary[...]